You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 24, December 27, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Controversies
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (19)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Law and Medicine
 •Medical Ethics
 •Alert me on articles by topic

The Ethical Validity of Using Nuclear Transfer in Human Transplantation

Robert P. Lanza, MD; Arthur L. Caplan, PhD; Lee M. Silver, PhD; Jose B. Cibelli, PhD; Michael D. West, PhD; Ronald M. Green, PhD

JAMA. 2000;284:3175-3179.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Therapeutic cloning (or cell replacement by means of nuclear transfer) is a new biomedical technology that has the potential to transform medicine. Therapeutic cloning involves the transfer of the nucleus from one of the patient's cells into an enucleated donor oocyte for the purpose of making medically useful and immunologically compatible cells and tissues (Figure 1).1 Although the phrase "therapeutic cloning" has been most widely used in this context, we believe that it is misleading. "Cloning" brings to mind images of the replication of a single genome for reproductive purposes. In therapeutic cloning, however, no such replication is involved. For this reason, we prefer the term "cell replacement through nuclear transfer" (CRNT). In this article, we use both terms so that readers may become . . . [Full Text of this Article]

Scientific Background

Author Affiliations: Advanced Cell Technology, Worcester, Mass (Drs Lanza, Cibelli, and West); Center for Bioethics, University of Pennsylvania Medical Center, Philadelphia (Dr Caplan); Department of Molecular Biology and Woodrow Wilson School of Public and International Affairs, Princeton University, Princeton, NJ (Dr Silver); and Ethics Institute, Dartmouth College, Hanover, NH (Dr Green).


RELATED ARTICLE

The Ethics of Embryonic Stem Cells—Now and Forever, Cells Without End
Eric Juengst and Michael Fossel
JAMA. 2000;284(24):3180-3184.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Discourse on Embryo Science and Human Cloning in the United States and Great Britain: 1984 2002
Weed
J Law Med Ethics 2005;33:802-810.
 

Regeneration of the Infarcted Heart With Stem Cells Derived by Nuclear Transplantation
Lanza et al.
Circ. Res. 2004;94:820-827.
ABSTRACT | FULL TEXT  

Is There an Antiaging Medicine?
Butler et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2002;57:B333-338.
ABSTRACT | FULL TEXT  

Ethical Issues in Embryonic Stem Cell Research
Cohen et al.
JAMA 2001;285:1439-1440.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.